Sunburst Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-2,488
Closed -$219K – 88
2023
Q2
$219K Buy
+2,488
New +$214K 0.08% 88
2022
Q3
– Sell
-2,286
Closed -$205K – 85
2022
Q2
$205K Sell
2,286
-351
-13% -$35.6K 0.1% 80
2022
Q1
$293K Hold
2,637
– – 0.14% 62
2021
Q4
$273K Hold
2,637
– – 0.14% 60
2021
Q3
$331K Hold
2,637
– – 0.21% 48
2021
Q2
$327K Sell
2,637
-61
-2% -$7.66K 0.21% 49
2021
Q1
$319K Buy
2,698
+412
+18% +$48.3K 0.22% 48
2020
Q4
$268K Buy
2,286
+8
+0.4% +$881 0.2% 49
2020
Q3
$237K Sell
2,278
-25
-1% -$2.51K 0.2% 52
2020
Q2
$211K Sell
2,303
-72
-3% -$6.9K 0.19% 53
2020
Q1
$214K Hold
2,375
– – 0.23% 47
2019
Q4
$269K Buy
+2,375
New +$261K 0.23% 50

Other funds holding MDT

Sunburst Financial Group's MDT Position: Q3 2023 in Review

Sunburst Financial Group sold out of Medtronic (MDT) in Q3 2023, closing a stake of 2,488 shares — an estimated $219K sold.

Sunburst Financial Group first reported a position in MDT in Q4 2019 and held it in 12 quarters. The position peaked at $331K in Q3 2021. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Sunburst Financial Group reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Sunburst Financial Group sold 2,488 Medtronic shares in Q3 2023, an estimated $219K.
  • Sunburst Financial Group first reported a position in Medtronic in Q4 2019 and held it in 12 quarters.
  • Sunburst Financial Group's Medtronic position peaked at $331K in Q3 2021.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Sunburst Financial Group's 13F filing for Q3 2023, filed 19 Oct 2023.